Doxorubicin Completed Phase 1 Trials for Neuroectodermal Tumors, Primitive / Sarcomas / Sarcoma, Osteogenic / Neuroepithelioma / Ewing's Sarcoma (ES) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00001209A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
NCT00004123Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma
NCT00004109Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
NCT00030784Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
NCT00742924Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT01605526A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma